% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@INBOOK{Kaniyappan:165567,
      author       = {Kaniyappan, Senthilvelrajan and Balaji, Varun and Wang,
                      Yipeng and Mandelkow, Eckhard},
      title        = {{M}icrofluidic {C}hamber {T}echnology to {S}tudy
                      {M}issorting and {S}preading of {T}au {P}rotein in
                      {A}lzheimer's {D}isease.},
      volume       = {2551},
      address      = {New York, NY},
      publisher    = {Springer US},
      reportid     = {DZNE-2022-01707},
      isbn         = {978-1-0716-2596-5 (print)},
      series       = {Methods in Molecular Biology},
      pages        = {111 - 123},
      year         = {2023},
      comment      = {Protein Aggregation / Cieplak, Andrzej Stanisław (Editor)
                      ; New York, NY : Springer US, 2023, Chapter 9 ; ISSN:
                      1064-3745=1940-6029 ; ISBN:
                      978-1-0716-2596-5=978-1-0716-2597-2 ;
                      doi:10.1007/978-1-0716-2597-2},
      booktitle     = {Protein Aggregation / Cieplak, Andrzej
                       Stanisław (Editor) ; New York, NY :
                       Springer US, 2023, Chapter 9 ; ISSN:
                       1064-3745=1940-6029 ; ISBN:
                       978-1-0716-2596-5=978-1-0716-2597-2 ;
                       doi:10.1007/978-1-0716-2597-2},
      abstract     = {Tau is a microtubule-associated protein found mainly in the
                      axons of neurons in the brain. Abnormal changes in Tau
                      (e.g., aggregation, hyperphosphorylation) are hallmarks of
                      Alzheimer's disease. Two processes of relocalization of Tau
                      may be related to early states of the pathology and have
                      received much attention: (1) the redistribution of Tau
                      within cells (termed 'somatodendritic missorting') and (2)
                      the release and reuptake of Tau from donor to acceptor cells
                      (termed 'spreading'). Because of the tripartite nature of
                      neurons (cell body, dendrites, axons), these changes can be
                      studied by microfluidic chambers (MFCs) which allow
                      separation and observation of Tau in neuronal compartments.
                      In this chapter, we present some methods and research
                      results obtained by using microfluidic devices.},
      keywords     = {Humans / tau Proteins: metabolism / Alzheimer Disease:
                      metabolism / Microfluidics / Neurons: metabolism / Axons:
                      metabolism / Microfluidic chambers (Other) / Missorting
                      (Other) / Primary neurons (Other) / Spreading (Other) / Tau
                      (Other) / tau Proteins (NLM Chemicals)},
      cin          = {AG Mandelkow 1 / AG Mandelkow 2},
      ddc          = {570},
      cid          = {I:(DE-2719)1013014 / I:(DE-2719)1013015},
      pnm          = {352 - Disease Mechanisms (POF4-352)},
      pid          = {G:(DE-HGF)POF4-352},
      typ          = {PUB:(DE-HGF)7},
      pubmed       = {pmid:36310200},
      doi          = {10.1007/978-1-0716-2597-2_9},
      url          = {https://pub.dzne.de/record/165567},
}